D. E. Shaw & Co. Inc. Buys New Stake in iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE)
D. E. Shaw & Co. Inc. purchased a new position in iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE – Free Report) during the 4th quarter, according to its most recent 13F filing with the SEC. The firm purchased 6,040 shares of the company’s stock, valued at approximately $397,000. Other hedge funds and other institutional investors also recently […]
D. E. Shaw & Co. Inc. purchased a new position in iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE – Free Report) during the 4th quarter, according to its most recent 13F filing with the SEC. The firm purchased 6,040 shares of the company’s stock, valued at approximately $397,000. Other hedge funds and other institutional investors also recently […]
